124 related articles for article (PubMed ID: 32234922)
21. Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
Chen L; Shen C; Redmond KJ; Page BR; Kummerlowe M; Mcnutt T; Bettegowda C; Rigamonti D; Lim M; Kleinberg L
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):939-947. PubMed ID: 28602418
[TBL] [Abstract][Full Text] [Related]
22. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
23. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
24. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
25. Hypofractionated whole-brain radiotherapy for multiple brain metastases from transitional cell carcinoma of the bladder.
Rades D; Meyners T; Veninga T; Stalpers LJ; Schild SE
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):404-8. PubMed ID: 20171794
[TBL] [Abstract][Full Text] [Related]
26. Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis.
Buecker R; Hong ZY; Liu XM; Jaenke G; Lu P; Schaefer U
Radiat Oncol; 2019 Mar; 14(1):41. PubMed ID: 30866972
[TBL] [Abstract][Full Text] [Related]
27. Overall Survival After Whole-Brain Radiation Therapy for Intracerebral Metastases from Testicular Cancer.
Rades D; Dziggel L; Veninga T; Bajrovic A; Schild SE
Anticancer Res; 2016 Sep; 36(9):4817-9. PubMed ID: 27630334
[TBL] [Abstract][Full Text] [Related]
28. Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
Bernhardt D; Bozorgmehr F; Adeberg S; Opfermann N; von Eiff D; Rieber J; Kappes J; Foerster R; König L; Thomas M; Debus J; Steins M; Rieken S
Lung Cancer; 2016 Nov; 101():76-81. PubMed ID: 27794411
[TBL] [Abstract][Full Text] [Related]
29. What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach.
Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Atalar B; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):688-93. PubMed ID: 22445007
[TBL] [Abstract][Full Text] [Related]
30. A Scoring Tool to Estimate the Survival of Elderly Patients With Brain Metastases from Esophageal Cancer Receiving Whole-brain Irradiation.
Nguyen T; Bartscht T; Schild SE; Rades D
Anticancer Res; 2020 Mar; 40(3):1661-1664. PubMed ID: 32132071
[TBL] [Abstract][Full Text] [Related]
31. Treatment of five or more brain metastases with stereotactic radiosurgery.
Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
[TBL] [Abstract][Full Text] [Related]
32. Development of a Survival Score for Patients with Cerebral Metastases from Melanoma.
Sehmisch L; Schild SE; Rades D
Anticancer Res; 2017 Jan; 37(1):249-252. PubMed ID: 28011499
[TBL] [Abstract][Full Text] [Related]
33. Predictors of survival in patients with brain metastases from gastric cancer.
Rades D; Bartscht T; Schild SE
Neoplasma; 2017; 64(1):136-139. PubMed ID: 27881015
[TBL] [Abstract][Full Text] [Related]
34. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
35. Predicting overall survival in patients with brain metastases from esophageal cancer.
Rades D; Dziggel L; Bartscht T; Gliemroth J
Anticancer Res; 2014 Nov; 34(11):6763-5. PubMed ID: 25368288
[TBL] [Abstract][Full Text] [Related]
36. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
37. Number of involved extracranial organs predicts survival in patients with brain metastasis from small cell lung cancer.
Gerdan L; Šegedin B; Veninga T; Schild SE; Rades D
Anticancer Res; 2013 Sep; 33(9):3887-9. PubMed ID: 24023324
[TBL] [Abstract][Full Text] [Related]
38. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for survival and intracerebral control after irradiation for brain metastases from gynecological cancer.
Rades D; Fischer D; Veninga T; Stalpers LJ; Schild SE
Gynecol Oncol; 2009 Sep; 114(3):506-8. PubMed ID: 19540574
[TBL] [Abstract][Full Text] [Related]
40. Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.
Rades D; Kueter JD; Meyners T; Pluemer A; Veninga T; Gliemroth J; Schild SE
Clin Neurol Neurosurg; 2012 May; 114(4):326-30. PubMed ID: 22152784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
